NCT02454725

Brief Summary

Early HIV diagnosis followed by linkage to treatment soon after HIV infection can reduce mortality and prevent new HIV infections. To obtain the full benefit of early HIV diagnosis, the US Centers for Disease Control and Prevention suggest that high risk groups get tested for HIV regularly, every three to six months. This study will examine the feasibility of a strategy to promote regular HIV testing and HIV risk reduction among Latino men at risk for HIV which, if successful, will help to identify Latino men unaware of their HIV status, benefitting them and the society.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 27, 2015

Completed
5 days until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

February 4, 2019

Status Verified

January 1, 2019

Enrollment Period

3 years

First QC Date

April 20, 2015

Last Update Submit

January 31, 2019

Conditions

Keywords

HIV TestingLatino

Outcome Measures

Primary Outcomes (1)

  • Frequency of HIV testing

    Maximum number of months between two HIV tests

    Twelve months post intervention

Secondary Outcomes (3)

  • Frequency of HIV testing

    Twelve months post intervention

  • HIV risk behaviors: Number of unprotected anal intercourse occasions with a non-monogamous partner

    Twelve months post intervention

  • HIV risk behaviors: Number of sexual partners

    Twelve months post intervention

Study Arms (2)

Social Network

EXPERIMENTAL

Leaders of social networks will communicate messages endorsing regular HIV testing to network members.

Behavioral: Social NetworkBehavioral: Comparison

Comparison

ACTIVE COMPARATOR

HIV counseling and testing

Behavioral: Comparison

Interventions

Social NetworkBEHAVIORAL

Leaders of social networks will undergo small group training to develop skills to convey information effectively and deliver messages endorsing regular HIV testing to members of their social networks.

Social Network
ComparisonBEHAVIORAL

All participants will receive HIV counseling and rapid testing following the Wisconsin Department of Health guidelines. Sexually active men who receive a negative test result will be told that they should be HIV-tested every three to six months, unless they have a monogamous HIV negative partner

Also known as: HIV Counseling and Testing
ComparisonSocial Network

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • self-report as a Latino man who has sex with men (LMSM);
  • living in the Milwaukee area;
  • willing and able to provide consent for participation;
  • more than 70% of social network members are LMSM
  • more than 50% of LMSM social network members are at risk for HIV

You may not qualify if:

  • Female
  • years of age or younger
  • Unable to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Laura R. Glasman, Ph.D.

    Medical College of Wisconsin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2015

First Posted

May 27, 2015

Study Start

June 1, 2015

Primary Completion

June 1, 2018

Study Completion

June 1, 2018

Last Updated

February 4, 2019

Record last verified: 2019-01